His primary scientific interests are in Internal medicine, Pancreatic cancer, Oncology, Adenocarcinoma and Surgery. His research ties Gastroenterology and Internal medicine together. Pancreatic cancer is a subfield of Cancer that he investigates.
His Oncology research incorporates elements of Pancreatectomy, Exocrine pancreas, Lymph node and Clinical trial. His research integrates issues of Pancreatic disease, Radiation therapy, Pancreaticoduodenectomy and General surgery in his study of Adenocarcinoma. His work investigates the relationship between Surgery and topics such as Lymphadenectomy that intersect with problems in Primary sclerosing cholangitis, Bile duct, Percutaneous transhepatic cholangiography and Liver transplantation.
Joseph M. Herman focuses on Internal medicine, Oncology, Pancreatic cancer, Radiation therapy and Radiology. The various areas that Joseph M. Herman examines in his Internal medicine study include Gastroenterology and Surgery. He studied Oncology and Survival rate that intersect with Surgical oncology.
His biological study spans a wide range of topics, including Pancreatectomy, Pancreas, Disease, Gemcitabine and Chemoradiotherapy. In his study, Image-guided radiation therapy is strongly linked to Nuclear medicine, which falls under the umbrella field of Radiation therapy. His Radiology study integrates concerns from other disciplines, such as Colorectal cancer and Resection.
His main research concerns Pancreatic cancer, Radiology, Radiation therapy, Internal medicine and Cancer. His Pancreatic cancer research integrates issues from Stereotactic body radiation therapy, Clinical trial, Gemcitabine, Chemotherapy and Pancreatectomy. His Radiation therapy research includes elements of Stage and Proportional hazards model.
His Internal medicine study combines topics in areas such as Gastroenterology and Oncology. Joseph M. Herman has researched Gastroenterology in several fields, including Hepatocellular carcinoma, Lymphocyte and Adenocarcinoma. The Cancer study combines topics in areas such as Radiation oncology, Medical physics and Family medicine.
His primary scientific interests are in Pancreatic cancer, Internal medicine, Radiology, Radiation therapy and Pancreatectomy. His Pancreatic cancer study incorporates themes from Regimen, Surgery, Physical therapy, Adjuvant therapy and Patient experience. His work carried out in the field of Internal medicine brings together such families of science as Gastroenterology and Oncology.
His Radiology research incorporates themes from Chemotherapy and MEDLINE. In general Radiation therapy study, his work on Particle therapy often relates to the realm of Steering committee, thereby connecting several areas of interest. His work deals with themes such as Cancer and Retrospective cohort study, which intersect with Pancreatectomy.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
DPC4 Gene Status of the Primary Carcinoma Correlates With Patterns of Failure in Patients With Pancreatic Cancer
Christine A. Iacobuzio-Donahue;Baojin Fu;Shinichi Yachida;Mingde Luo.
Journal of Clinical Oncology (2009)
Recent Progress in Pancreatic Cancer
Christopher L. Wolfgang;Joseph M. Herman;Daniel A. Laheru;Alison P. Klein.
CA: A Cancer Journal for Clinicians (2013)
Pancreatic adenocarcinoma, version 2.2017: Clinical practice guidelines in Oncology
Margaret A. Tempero;Mokenge P. Malafa;Mahmoud Al-Hawary;Horacio Asbun.
Journal of The National Comprehensive Cancer Network (2017)
Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Peter Peng;Omar Hyder;Amin Firoozmand;Peter Kneuertz.
Journal of Gastrointestinal Surgery (2012)
Computational Modeling of Pancreatic Cancer Reveals Kinetics of Metastasis Suggesting Optimum Treatment Strategies
Hiroshi Haeno;Mithat Gonen;Meghan B. Davis;Joseph M. Herman.
Preoperative Modified FOLFIRINOX Treatment Followed by Capecitabine-Based Chemoradiation for Borderline Resectable Pancreatic Cancer: Alliance for Clinical Trials in Oncology Trial A021101.
Matthew H.G. Katz;Qian Shi;Syed A. Ahmad;Joseph M. Herman.
JAMA Surgery (2016)
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma
Joseph M. Herman;Daniel T. Chang;Karyn A. Goodman;Avani S. Dholakia.
Impact of Total Lymph Node Count and Lymph Node Ratio on Staging and Survival after Pancreatectomy for Pancreatic Adenocarcinoma: A Large, Population-Based Analysis
Mark B. Slidell;David C. Chang;John L. Cameron;Christopher Wolfgang.
Annals of Surgical Oncology (2008)
SMAD4 Gene Mutations Are Associated with Poor Prognosis in Pancreatic Cancer
Amanda Blackford;Oscar K. Serrano;Christopher L. Wolfgang;Giovanni Parmigiani.
Clinical Cancer Research (2009)
Pancreatic Adenocarcinoma, Version 2.2014
Margaret A. Tempero;Mokenge P. Malafa;Stephen W. Behrman;Al B. Benson.
Journal of The National Comprehensive Cancer Network (2014)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: